11/30/2021NiKang and Pfizer Ink Clinical Agreement over Novel Combo Therapies fo...

11/29/2021 GSK/ViiV Healthcare Files NDA for HIV Drug Cabotegravir in China

11/29/2021PhIIC: Chinese Retail Pharmacy Market on Steady Growth 2019 - H1/2021

11/29/2021NHSA Issues Three-Year Action Plan on DRD/DIP Payment System Reform (S...

11/29/2021Clinical Value A Top Priority in Cancer Drug Trials, CDE Says (PharmaD...

11/26/2021CDE Issued the Technical Requirements for Pharmaceutical Research of I...

11/26/2021CDE Issues the Requirements for Pharmaceutical Study Common Questions ...

11/26/2021CDE Solicits Comments the Guidelines for Evaluation of Immune-Related ...

11/26/2021Nhwa Pharma Licenses China Rights of Lundbeck's Shelved Schizophrenia ...

11/26/2021Luye Subsidiary Boan Bio Signs MOU with Merck to Build Next-Gen Digit...

11/26/2021JPO Publicizes 6th VBP Tender Outcome, Which Slashes Insulin Prices by...

11/26/2021Novo Nordisk Announces Impact from Volume Based Procurement for Insuli...

11/26/2021Simcere Announces CN Conditional Approval of Enweida (Envafolimab) C...

11/26/2021Recent Executive Movements

11/25/2021Chugai Files China's First Case of Patent Linkage at Beijing IP Court

11/25/2021China Issues IPR Protection, Application Plan in 2021-2025 Period

11/24/2021HUTCHMED and AZ Initiate SACHI P3 Trial of ORPATHYS and TAGRISSO Com...

11/24/2021NMPA Announces Package Insert Revision of Disodium Clodronate Formulat...

11/24/2021TenNor Reports Positive Results of TNP-2092 Capsule for Liver Cirrhosi...

11/24/2021Pfizer Sues Employee for Allegedly Stealing Covid-19 Vaccine Secrets

11/24/2021BeiGene Completes Acquisition of Former BMS Campus in NJ

11/24/2021BeiGene Wins EU Approval of BRUKINSA for Waldenström's Macroglobuline...

11/24/2021API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...

11/23/2021Patent Invalidation Strategies in Patent Infringement Disputes

11/23/2021China Emphasizes Clinical Value While the U.S. Reviews Cell Therapy wi...

11/23/2021PharmaDJ's China Licensing Deals Tracker: October 2021

11/23/2021NHC Issues Notice on Promotion of Sanming City's Healthcare Reform Exp...

11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...

11/23/2021Lonza and Bluejay Therapeutics Ink Manufacturing Deal

11/23/2021Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from...

Page:159/774 Total number of articles:23207: [First][<<] [157] [158] [159] [160] [161] [>>] [End]